291 related articles for article (PubMed ID: 20647562)
1. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI).
Guagliumi G; Sirbu V; Musumeci G; Bezerra HG; Aprile A; Kyono H; Fiocca L; Matiashvili A; Lortkipanidze N; Vassileva A; Popma JJ; Allocco DJ; Dawkins KD; Valsecchi O; Costa MA
Circ Cardiovasc Interv; 2010 Aug; 3(4):367-75. PubMed ID: 20647562
[TBL] [Abstract][Full Text] [Related]
2. A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent.
Grube E; Schofer J; Hauptmann KE; Nickenig G; Curzen N; Allocco DJ; Dawkins KD
JACC Cardiovasc Interv; 2010 Apr; 3(4):431-8. PubMed ID: 20398872
[TBL] [Abstract][Full Text] [Related]
3. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
[TBL] [Abstract][Full Text] [Related]
5. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y; Hara M; Sakata Y; Hamasaki T; Nishino M
EuroIntervention; 2014 Dec; 10(8):924-33. PubMed ID: 24602858
[TBL] [Abstract][Full Text] [Related]
6. The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss.
Lee SWL; Tam FCC; Lam SCC; Kong SL; Shea CP; Chan KKW; Wong MKL; Chan MPH; Wong AYT; Yung ASY; Lam YM; Zhang LW; Wu KKY; Mintz GS; Maehara A
Circ Cardiovasc Interv; 2018 Apr; 11(4):e006034. PubMed ID: 29654119
[TBL] [Abstract][Full Text] [Related]
7. Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.
Otake H; Honda Y; Courtney BK; Shimohama T; Ako J; Waseda K; Macours N; Rogers C; Popma JJ; Abizaid A; Ormiston JA; Spaulding C; Cohen SA; Fitzgerald PJ
Circ Cardiovasc Interv; 2011 Apr; 4(2):146-54. PubMed ID: 21386089
[TBL] [Abstract][Full Text] [Related]
8. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
[TBL] [Abstract][Full Text] [Related]
9. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.
Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M
JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468
[TBL] [Abstract][Full Text] [Related]
10. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
11. Early vascular healing with biodegradable polymer coated sirolimus-eluting coronary stent implantation: assessed by optical coherence tomography results at 4-month follow-up.
Abhyankar A; Prajapati J; Reddy S; Reddy S
Minerva Cardioangiol; 2013 Jun; 61(3):313-22. PubMed ID: 23681134
[TBL] [Abstract][Full Text] [Related]
12. First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting stent in de novo coronary artery disease: results of the first in man FIREHAWK trial.
Qian J; Xu B; Lansky AJ; Yang YJ; Qiao SB; Wu YJ; Chen J; Hu FH; Yang WX; Mintz GS; Leon MB; Gao RL
Chin Med J (Engl); 2012 Mar; 125(6):970-6. PubMed ID: 22613516
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
14. Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.
Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
Int J Cardiovasc Imaging; 2018 Apr; 34(4):515-522. PubMed ID: 29159531
[TBL] [Abstract][Full Text] [Related]
15. Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months).
Chevalier B; Smits PC; Carrié D; Mehilli J; Van Boven AJ; Regar E; Sawaya FJ; Chamié D; Kraaijeveld AO; Hovasse T; Vlachojannis GJ
Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246909
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
17. An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9.
Davlouros PA; Mavronasiou E; Xanthopoulou I; Karantalis V; Tsigkas G; Hahalis G; Alexopoulos D
Int J Cardiol; 2012 Jun; 157(3):341-6. PubMed ID: 21220173
[TBL] [Abstract][Full Text] [Related]
18. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
20. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.
Barlis P; Regar E; Serruys PW; Dimopoulos K; van der Giessen WJ; van Geuns RJ; Ferrante G; Wandel S; Windecker S; van Es GA; Eerdmans P; Jüni P; di Mario C
Eur Heart J; 2010 Jan; 31(2):165-76. PubMed ID: 19889649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]